157 related articles for article (PubMed ID: 10935350)
1. Topical anthralin for psoriasis vulgaris: evaluation of 70 Japanese patients.
Yamamoto T; Matsuuchi M; Irimajiri J; Otoyama K; Nishioka K
J Dermatol; 2000 Jul; 27(7):482-5. PubMed ID: 10935350
[TBL] [Abstract][Full Text] [Related]
2. A comparative study of calcipotriol and anthralin for chronic plaque psoriasis in a day care treatment center.
Dutz JP; Lui H
Int J Dermatol; 1998 Jan; 37(1):51-3. PubMed ID: 9522242
[TBL] [Abstract][Full Text] [Related]
3. Topical anthralin therapy for refractory nail psoriasis.
Yamamoto T; Katayama I; Nishioka K
J Dermatol; 1998 Apr; 25(4):231-3. PubMed ID: 9609979
[TBL] [Abstract][Full Text] [Related]
4. [Anthralin therapy of psoriasis--a retrospective study of 39 cases].
Higashi K; Katayama I; Nishioka K; Nishiyama S
Nihon Hifuka Gakkai Zasshi; 1989 Feb; 99(2):129-34. PubMed ID: 2746967
[TBL] [Abstract][Full Text] [Related]
5. Alteration of the expression of Bcl-2, Bcl-x, Bax, Fas, and Fas ligand in the involved skin of psoriasis vulgaris following topical anthralin therapy.
Yamamoto T; Nishioka K
Skin Pharmacol Appl Skin Physiol; 2003; 16(1):50-8. PubMed ID: 12566829
[TBL] [Abstract][Full Text] [Related]
6. [Classical topical therapy of psoriasis].
Gerdes S; Mrowietz U
Hautarzt; 2006 Aug; 57(8):666-71. PubMed ID: 16841204
[TBL] [Abstract][Full Text] [Related]
7. Twice-daily vs. once-daily inpatient dithranol for psoriasis.
Kirkup ME; Sabroe RA; Kavanagh GM; Downs AM; Sansom JE; de Berker DA; Dunnill MG; Kennedy CT; Archer CB
Clin Exp Dermatol; 2002 Nov; 27(8):695-9. PubMed ID: 12472549
[TBL] [Abstract][Full Text] [Related]
8. Anthralin for psoriasis: short-contact anthralin therapy compared with topical steroid and conventional anthralin.
Lowe NJ; Ashton RE; Koudsi H; Verschoore M; Schaefer H
J Am Acad Dermatol; 1984 Jan; 10(1):69-72. PubMed ID: 6693604
[TBL] [Abstract][Full Text] [Related]
9. Phototherapy of psoriasis: comparative experience of different phototherapeutic approaches.
Karrer S; Eholzer C; Ackermann G; Landthaler M; Szeimies RM
Dermatology; 2001; 202(2):108-15. PubMed ID: 11306830
[TBL] [Abstract][Full Text] [Related]
10. The irritancy of anthralin is inhibited by repeat applications of a subirritant concentration.
Parslew R; Friedmann PS
Br J Dermatol; 1999 Sep; 141(3):469-74. PubMed ID: 10583050
[TBL] [Abstract][Full Text] [Related]
11. Treatment of plaque-type psoriasis with the 308 nm excimer laser in combination with dithranol or calcipotriol.
Rogalski C; Grunewald S; Schetschorke M; Bodendorf MO; Kauer F; Simon JC; Paasch U
Int J Hyperthermia; 2012; 28(2):184-90. PubMed ID: 22335232
[TBL] [Abstract][Full Text] [Related]
12. Topical antipsoriatics.
Smith KC; Lebwohl M
Skin Therapy Lett; 2000; 5(2):1-2. PubMed ID: 10751842
[TBL] [Abstract][Full Text] [Related]
13. Measurement of the response of psoriasis to short-term application of anthralin.
Marsden JR; Coburn PR; Marks J; Shuster S
Br J Dermatol; 1983 Aug; 109(2):209-18. PubMed ID: 6871098
[TBL] [Abstract][Full Text] [Related]
14. Paper-tape occlusion of anthralin paste. A new outpatient therapy for psoriasis.
Pearlman DL; Burns J; Cannon TC; Engelhard CS
Arch Dermatol; 1984 May; 120(5):625-30. PubMed ID: 6721524
[TBL] [Abstract][Full Text] [Related]
15. Anthralin. Different concentration effects on epidermal cell DNA synthesis rates in mice and clinical responses in human psoriasis.
Lowe NJ; Breeding J
Arch Dermatol; 1981 Nov; 117(11):698-700. PubMed ID: 7316528
[TBL] [Abstract][Full Text] [Related]
16. Anthralin cream as short contact therapy for psoriasis.
Miller AC
Cutis; 1985 Jun; 35(6):578-82. PubMed ID: 4017653
[TBL] [Abstract][Full Text] [Related]
17. A topical treatment program for psoriasis with low anthralin concentrations.
Brody I; Johansson A
J Cutan Pathol; 1977 Oct; 4(5):233-43. PubMed ID: 342554
[TBL] [Abstract][Full Text] [Related]
18. Optimization of topical therapy of psoriasis.
Wohlrab W; Wozniak KD; Taube KM
Acta Univ Carol Med (Praha); 1986; 32(3-4):249-54. PubMed ID: 3434484
[No Abstract] [Full Text] [Related]
19. Optimizing the frequency of outpatient short-contact dithranol treatment used in combination with broadband ultraviolet B for psoriasis: a randomized, within-patient controlled trial.
McBride SR; Walker P; Reynolds NJ
Br J Dermatol; 2003 Dec; 149(6):1259-65. PubMed ID: 14674905
[TBL] [Abstract][Full Text] [Related]
20. The effect of triethanolamine application on anthralin-induced inflammation and therapeutic effect in psoriasis.
Ramsay B; Lawrence CM; Bruce JM; Shuster S
J Am Acad Dermatol; 1990 Jul; 23(1):73-6. PubMed ID: 2142172
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
